JPWO2020204172A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020204172A5 JPWO2020204172A5 JP2021512327A JP2021512327A JPWO2020204172A5 JP WO2020204172 A5 JPWO2020204172 A5 JP WO2020204172A5 JP 2021512327 A JP2021512327 A JP 2021512327A JP 2021512327 A JP2021512327 A JP 2021512327A JP WO2020204172 A5 JPWO2020204172 A5 JP WO2020204172A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- alkyl
- pharmaceutically acceptable
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019072910 | 2019-04-05 | ||
| JP2019072910 | 2019-04-05 | ||
| PCT/JP2020/015359 WO2020204172A1 (ja) | 2019-04-05 | 2020-04-03 | 水溶性アジュバント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020204172A1 JPWO2020204172A1 (https=) | 2020-10-08 |
| JPWO2020204172A5 true JPWO2020204172A5 (https=) | 2023-04-12 |
| JP7539867B2 JP7539867B2 (ja) | 2024-08-26 |
Family
ID=72668226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512327A Active JP7539867B2 (ja) | 2019-04-05 | 2020-04-03 | 水溶性アジュバント |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12427192B2 (https=) |
| EP (1) | EP3949983A4 (https=) |
| JP (1) | JP7539867B2 (https=) |
| KR (1) | KR102921677B1 (https=) |
| CN (1) | CN113966326A (https=) |
| CA (1) | CA3136182A1 (https=) |
| MX (1) | MX2021012201A (https=) |
| WO (1) | WO2020204172A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022327884A1 (en) * | 2021-08-12 | 2024-02-22 | International Institute Of Cancer Immunology, Inc. | Pharmaceutical composition and method for treatment or prevention of cancer |
| US20240115503A1 (en) * | 2021-11-17 | 2024-04-11 | Lipella Pharmaceuticals Inc. | Intravesical delivery of hydrophilic therapeutic agents using liposomes |
| US12036318B2 (en) * | 2022-02-16 | 2024-07-16 | Chemical & Schutz High Performance Lubricants, S.A. De C.V. | Self-emulsionable mineral oil as a vehicle in vaccines for poultry |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06002199A (es) * | 2003-08-27 | 2006-05-22 | 3M Innovative Properties Co | Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi. |
| WO2006078059A1 (ja) | 2005-01-19 | 2006-07-27 | Dainippon Sumitomo Pharma Co., Ltd. | 希釈用乳化組成物および癌ワクチン組成物 |
| ES2352855T3 (es) | 2005-11-30 | 2011-02-23 | International Institute Of Cancer Immunology, Inc. | Nuevos compuestos peptídicos del tumor de wilms. |
| PE20091236A1 (es) | 2007-11-22 | 2009-09-16 | Astrazeneca Ab | Derivados de pirimidina como immunomoduladores de tlr7 |
| KR20110117705A (ko) * | 2009-02-11 | 2011-10-27 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 톨-유사 수용체 조정제 및 질병의 치료 |
| JO3257B1 (ar) * | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
| ES2458355T3 (es) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorción de inmunopotenciadores sobre sales metálicas insolubles |
| WO2012066336A1 (en) | 2010-11-19 | 2012-05-24 | Astrazeneca Ab | Benzylamine compounds as toll -like receptor 7 agonists |
| MY171854A (en) | 2013-03-29 | 2019-11-05 | Sumitomo Dainippon Pharma Co Ltd | Wt1 antigen peptide conjugate vaccine |
| EP2980097A4 (en) | 2013-03-29 | 2017-03-08 | Sumitomo Dainippon Pharma Co., Ltd. | Conjugate vaccine using trimming function of erap1 |
| SG11201802832UA (en) | 2015-10-07 | 2018-05-30 | Sumitomo Dainippon Pharma Co Ltd | Pyrimidine compound |
| WO2017102652A1 (en) | 2015-12-14 | 2017-06-22 | Glaxosmithkline Biologicals S.A. | Pegylated imidazoquinolines as tlr7 and tlr8 agonists |
| EP3510036B1 (en) * | 2016-09-07 | 2021-07-21 | GlaxoSmithKline Biologicals SA | Imidazoquinoline derivatives and their use in therapy |
| KR102619747B1 (ko) * | 2017-01-10 | 2023-12-29 | 넥타르 테라퓨틱스 | Tlr 효현제 화합물의 다중-아암 중합체 컨쥬게이트 및 관련 면역 요법적 치료 방법 |
| PL3603619T3 (pl) | 2017-03-29 | 2025-11-17 | Sumitomo Pharma Co., Ltd. | Preparat adjuwantu szczepionkowego |
-
2020
- 2020-04-03 EP EP20784003.4A patent/EP3949983A4/en active Pending
- 2020-04-03 CN CN202080041623.7A patent/CN113966326A/zh active Pending
- 2020-04-03 CA CA3136182A patent/CA3136182A1/en active Pending
- 2020-04-03 KR KR1020217033615A patent/KR102921677B1/ko active Active
- 2020-04-03 MX MX2021012201A patent/MX2021012201A/es unknown
- 2020-04-03 US US17/600,919 patent/US12427192B2/en active Active
- 2020-04-03 JP JP2021512327A patent/JP7539867B2/ja active Active
- 2020-04-03 WO PCT/JP2020/015359 patent/WO2020204172A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020204172A5 (https=) | ||
| KR100268654B1 (ko) | 아미노산 결합된 질소 머스타드 유도체 및 이를 종양 치료에 약물 전구체로서 사용하는 방법 | |
| US10005804B2 (en) | TC-PTP inhibitors as APC activators for immunotherapy | |
| US9642804B2 (en) | Cationic lipids with various head groups for oligonucleotide delivery | |
| JP7169968B2 (ja) | ワクチンアジュバント製剤 | |
| Wu et al. | Structure− activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides | |
| JP2010528089A5 (https=) | ||
| JPH10508858A (ja) | 改良抗ウイルス性プロドラッグ | |
| EP2125007A2 (en) | Conjugates of synthetic tlr agonists and uses therefor | |
| JP7695789B2 (ja) | ホスホ抗原プロドラッグ化合物 | |
| JP2024023349A5 (https=) | ||
| WO2009120999A2 (en) | Use of an endoxifen prodrug for treatment of breast cancer | |
| WO1991011994A1 (fr) | Inhibiteur de la formation de lipoproteines denaturees de faible densite | |
| EP3784662B1 (fr) | Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices | |
| RU2319692C2 (ru) | Производные тетрагидрокарбазола, способ получения производных тетрагидрокарбазола (варианты), их применение (варианты) и фармацевтическая композиция, обладающая активностью антагониста гонадотропин-рилизинг-гормона (варианты) | |
| CN1240451A (zh) | 药用氨基膦酸衍生物 | |
| JP2016526023A (ja) | Ｓｔａｔ６阻害剤 | |
| US20030220402A1 (en) | Cancer remedy comprising anthranilic acid derivatives as active ingredients | |
| JP2005527612A5 (https=) | ||
| JP2018529717A5 (https=) | ||
| RU2008111967A (ru) | Липосомальные композиции | |
| WO2011129837A1 (en) | Use of a 4-hydroxytoremifene prodrug for treatment of breast cancer | |
| JPWO2020204173A5 (https=) | ||
| ES2236971T3 (es) | Derivados del indol utiles, entre otras cosas, para el tratamiento de la osteoporosis. | |
| JPWO2023091490A5 (https=) |